CVAC - Pfizer Moderna to enjoy first mover advantage as COVID-19 expected to become endemic

With COVID-19 expected to become an endemic virus, the analysts project leading vaccine makers such as Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) to reap billions from COVID-19 booster shots until competitors arrive. Speaking to CNBC on Friday, Dr. Scott Gottlieb a former FDA commissioner said that coronavirus could reach endemic status in the U.S. and European countries after the current surge of cases wanes. Endemic viruses spread in a population at a lower frequency causing sporadic outbreaks such as seasonal flu. “We’re transitioning from this being a pandemic to being more of an endemic virus, at least here in the United States and probably other Western markets,” Gottlieb, who led the FDA from 2017 – 2019, remarked. An endemic situation requires regular booster shots resembling the market for flu vaccines which is estimated at more than 600M doses per year, according to Reuters. With Pfizer (PFE)/BioNTech (NASDAQ:BNTX) and Moderna (MRNA) COVID-19 vaccines

For further details see:

Pfizer, Moderna to enjoy first mover advantage as COVID-19 expected to become endemic